A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Undergoing Major Surgery.

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 2000

Primary Completion Date

November 30, 2003

Conditions
Haemophilia B
Interventions
BIOLOGICAL

Replenine®-VF (High Purity Factor IX)

Trial Locations (5)

RG24 9NA

North Hampshire Haemophilia Centre, Uplands House, North Hampshire Hospital, Aldermaston Road, Basingstoke

E1 1BB

Haemophilia Centre, The Royal London Hospital, White Chapel, London

NW3 2QG

Haemophilia Centre and Haemostasis Unit, Royal Free Hospital, Pond Street, London

M13 9WL

Manchester Thrombosis and Haemostasis Centre, University of Manchester, Department of Haematology, Manchester Royal Infirmary, Oxford Road, Manchester

SO16 6YD

Haemophilia Centre, Southampton General Hospital, Tremona Road, Southampton

Sponsors
All Listed Sponsors
lead

Bio Products Laboratory

OTHER